Hi Silsol,
Excellent outcome for this study being presented at a major USA conference.
Article in West Australian:
https://www.google.com.au/amp/s/thewest.com.au/business/public-companies/proteomics-outperforms-current-standard-with-kidney-test-c-4445722.amp
Your comment on becoming SOC - that’s what we all want to see & 3/4 of Drs in the US clinical utility study responded that they were likely to use PromarkerD, so that is really encouraging.
GLTAH
Ann: PromarkerD outperforms standard of care tests for DKD, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.005(1.41%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $116.7K | 323.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13166 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 113491 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |